A carregar...
A new oral testosterone undecanoate therapy comes of age for the treatment of hypogonadal men
BACKGROUND: A novel formulation of oral testosterone undecanoate (TU) was studied in a long- and short-term phase III trial to evaluate safety and efficacy. METHODS: Hypogonadal men (age 18–65 years; two morning serum testosterone (T) <300 ng/dl with signs/symptoms) were recruited into a 365 day...
Na minha lista:
| Publicado no: | Ther Adv Urol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7328356/ https://ncbi.nlm.nih.gov/pubmed/32655691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287220937232 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|